211 related articles for article (PubMed ID: 16075827)
1. Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.
Hirao K; Okishige K; Yamamoto N; Otomo K; Azegami K; Isobe M
Clin Cardiol; 2005 Jul; 28(7):338-42. PubMed ID: 16075827
[TBL] [Abstract][Full Text] [Related]
2. Pilsicainide for atrial fibrillation.
Kumagai K; Nakashima H; Tojo H; Yasuda T; Noguchi H; Matsumoto N; Ogawa M; Saku K
Drugs; 2006; 66(16):2067-73. PubMed ID: 17112301
[TBL] [Abstract][Full Text] [Related]
3. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
Turco P; De Simone A; La Rocca V; El Jamal B; Nocerino P; Astarita C; De Matteis C; Messina V; Greco L; Rotunno R; Di Napoli T; Vitale DF; Stabile G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S124-7. PubMed ID: 15683478
[TBL] [Abstract][Full Text] [Related]
5. Rate-dependent and site-specific conduction block at the posterior right atrium and drug effects evaluated using a noncontact mapping system in patients with typical atrial flutter.
Takami M; Yoshida A; Fukuzawa K; Takei A; Kanda G; Takami K; Kumagai H; Tanaka S; Itoh M; Imamura K; Fujiwara R; Suzuki A; Hirata K
J Cardiovasc Electrophysiol; 2012 Aug; 23(8):827-34. PubMed ID: 22452343
[TBL] [Abstract][Full Text] [Related]
6. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
Wazni O; Marrouche NF; Martin DO; Gillinov AM; Saliba W; Saad E; Klein A; Bhargava M; Bash D; Schweikert R; Erciyes D; Abdul-Karim A; Brachman J; Gunther J; Pisano E; Potenza D; Fanelli R; Natale A
Circulation; 2003 Nov; 108(20):2479-83. PubMed ID: 14610012
[TBL] [Abstract][Full Text] [Related]
7. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation.
Nabar A; Rodriguez LM; Timmermans C; van den Dool A; Smeets JL; Wellens HJ
Circulation; 1999 Mar; 99(11):1441-5. PubMed ID: 10086967
[TBL] [Abstract][Full Text] [Related]
8. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
[TBL] [Abstract][Full Text] [Related]
9. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
[TBL] [Abstract][Full Text] [Related]
10. Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs.
Kawabata M; Hirao K; Horikawa T; Suzuki K; Motokawa K; Suzuki F; Azegami K; Hiejima K
J Electrocardiol; 2001 Jan; 34(1):65-72. PubMed ID: 11239374
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.
Reithmann C; Dorwarth U; Dugas M; Hahnefeld A; Ramamurthy S; Remp T; Steinbeck G; Hoffmann E
Eur Heart J; 2003 Jul; 24(13):1264-72. PubMed ID: 12831821
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.
Peyrol M; Sbragia P; Bonello L; Lévy S; Paganelli F
Arch Cardiovasc Dis; 2011 Oct; 104(10):530-5. PubMed ID: 22044706
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
Bandini A; Golia P; Pantoli D; Galvani M; Rusticali F
Ital Heart J; 2005 Jul; 6(7):584-90. PubMed ID: 16274021
[TBL] [Abstract][Full Text] [Related]
15. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
[TBL] [Abstract][Full Text] [Related]
16. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation.
Reithmann C; Hoffmann E; Spitzlberger G; Dorwarth U; Gerth A; Remp T; Steinbeck G
Eur Heart J; 2000 Apr; 21(7):565-72. PubMed ID: 10775011
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
Schumacher B; Jung W; Lewalter T; Vahlhaus C; Wolpert C; Lüderitz B
Am J Cardiol; 1999 Mar; 83(5):710-3. PubMed ID: 10080423
[TBL] [Abstract][Full Text] [Related]
18. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
19. Early versus late atrial fibrillation after atrial flutter ablation.
Loutrianakis E; Barakat T; Olshansky B
J Interv Card Electrophysiol; 2002 Jun; 6(2):173-80. PubMed ID: 11992028
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological conversion of persistent atrial fibrillation into sinus rhythm with oral pilsicainide: pilsicainide suppression trial for persistent atrial fibrillation II.
Okishige K; Fukunami M; Kumagai K; Atarashi H; Inoue H;
Circ J; 2006 Jun; 70(6):657-61. PubMed ID: 16723783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
